Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2025)
Adaptive Biotechnologies (ADPT) has disclosed Other Non-Current Assets for 8 consecutive years, with $1.2 million as the latest value for Q4 2025.
- Quarterly Other Non-Current Assets fell 47.22% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 47.22% year-over-year, with the annual reading at $1.2 million for FY2025, 47.22% down from the prior year.
- Other Non-Current Assets hit $1.2 million in Q4 2025 for Adaptive Biotechnologies, down from $2.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.2 million in Q2 2024 to a low of $719000.0 in Q2 2021.
- Historically, Other Non-Current Assets has averaged $2.4 million across 5 years, with a median of $2.4 million in 2022.
- Biggest five-year swings in Other Non-Current Assets: crashed 65.76% in 2021 and later skyrocketed 240.19% in 2022.
- Year by year, Other Non-Current Assets stood at $2.1 million in 2021, then increased by 14.29% to $2.4 million in 2022, then increased by 22.17% to $2.9 million in 2023, then fell by 22.0% to $2.3 million in 2024, then tumbled by 47.22% to $1.2 million in 2025.
- Business Quant data shows Other Non-Current Assets for ADPT at $1.2 million in Q4 2025, $2.7 million in Q3 2025, and $2.7 million in Q2 2025.